> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Respironics Reports 111 Deaths in 3Q 2023: FDA
- URL: https://www.fdaweb.com/respironics-reports-111-deaths-in-3q-2023-fda/
- Published: 2024-01-31T12:00:00.000Z
- Updated: 2026-09-14T14:21:44.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5156265

Two days after Philips Respironics announced a consent decree ([see story](https://www.fdaweb.com/philips-respironics-fda-reach-consent-decree/)) where it would stop marketing its troubled ventilators, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) machines, FDA is now announcing [updated](https://www.fda.gov/medical-devices/recalled-philips-ventilators-bipap-machines-and-cpap-machines/problems-reported-recalled-philips-ventilators-bipap-machines-and-cpap-machines?ref=fdaweb.com#medical) medical device reports and reports of death associated with the devices.

According to the update, FDA has received over 7,000 [medical device reports (MDRs)](https://www.fda.gov/medical-devices/recalled-philips-ventilators-bipap-machines-and-cpap-machines/problems-reported-recalled-philips-ventilators-bipap-machines-and-cpap-machines?ref=fdaweb.com#medical) and 111 death reports from 7/2/2023 to 9/30/2023 that are reportedly associated with the breakdown or suspected breakdown of the polyester-based polyurethane (PE-PUR) foam used in Philips Respironics’ ventilators, BiPAP machines, and CPAP machines included in a recall announced 6/2021\. “Since April 2021, the FDA has received more than 116,000 MDRs, including 561 reports of death, reportedly associated with the PE-PUR foam breakdown or suspected foam breakdown,” the update says.